Envision Healthcare Holdings Inc
EVHC
EVHC was delisted on the 10th of October, 2018.
342 hedge funds and large institutions have $5.57B invested in Envision Healthcare Holdings Inc in 2018 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 111 increasing their positions, 134 reducing their positions, and 57 closing their positions.
122% more call options, than puts
Call options by funds: $63.4M | Put options by funds: $28.6M
13% more funds holding in top 10
Funds holding in top 10: 15 → 17 (+2)
4% less capital invested
Capital invested by funds: $5.83B → $5.57B (-$257M)
6% less funds holding
Funds holding: 364 → 342 (-22)
17% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 134
32% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 57
Top Buyers
Top Sellers
EVHC Hedge Fund Activity: Q3 2018 in Review
342 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Envision Healthcare Holdings Inc (EVHC) for Q3 2018, worth a combined $5.57B — down 4.4% from $5.83B a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of EVHC and 39 opened new positions — a net loss of 18 holders — while 134 trimmed existing stakes and 111 added.
The largest buyer was Farallon Capital Management, adding an estimated $203M. The largest seller was Maverick Capital, exiting entirely with an estimated $297M sold.
- 342 institutional investors held Envision Healthcare Holdings Inc (EVHC) as of Q3 2018, down from 364 in Q2 2018.
- Funds reported $5.57B of Envision Healthcare Holdings Inc stock for Q3 2018, down 4.4% quarter-over-quarter.
- 39 funds opened new Envision Healthcare Holdings Inc positions in Q3 2018 and 57 closed out, a net change of -18 holders.
- The largest Envision Healthcare Holdings Inc buyer in Q3 2018 was Farallon Capital Management, an estimated $203M added.
- The largest Envision Healthcare Holdings Inc seller in Q3 2018 was Maverick Capital, an estimated $297M sold.
Based on aggregated 13F filings for Q3 2018.